Summit Therapeutics - ADR Peer Comparison
$17.30
As on 30-Sep-2026 15:39EDT
Market cap
$12,453 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
20.8
Div. Yield
0 %
$17.30
As on 30-Sep-2026 15:39EDT
Market cap
$12,453 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
20.8
Div. Yield
0 %